Skin cancers are basically deformed growths resulting from many different causes and carry varying degrees of malignancy. The most propagable malignant skin cancers are Squamous cell carcinoma, basal cell carcinoma and melanoma.
Considered to be the most common form of skin cancer in humans. It develops in the basal cell layer of the skin and can be very damaging and disfiguring if neglected. Fortunately, this type of skin cancer rarely metastasizes beyond the skin surface and therefore it is considered to be the least dangerous. A biopsy often is the only test needed to determine the stage. In patients where the growth has metastasized to large areas of the skin, or has existed for a long time, the lymph nodes in the area of the spread will be investigated.
This type of cancer is mostly caused in areas extensively exposed to the sun, due to severe sunburn caused by ultraviolet radiation exposure. It is most common in the face and neck regions.
Considered to be the second most common type of skin cancers which originate in the surface area of the skin.
This type of cancer is divided into the following two types:
A biopsy often is the only test needed to determine the stage. In patients where the growth has metastasized to large areas of the skin, or has existed for a long time, the lymph nodes in the area of the spread will be investigated.
Considered to be the most aggressive type of skin cancers. It amounts to 5% of all skin malignancies. If not detected early, it may spread to other parts or regions of the body.
Please note the following regarding the treatment program:
As a result of 20 years of clinical research and trials, Heberferon was produced at the Center for Genetic Engineering and Biotechnology (CIGB) in Cuba. It’s objective is treat patients afflicted with skin cancer. It is administered through an injection and has the objective of eliminating or reducing non-melanoma skin tumors and prevent possible after-effects of facial surgeries.
Heberferon is made of a synergistic combination of Interferon alfa 2b and recombinant gamma. Its premier objective is to reduce or eliminate non-melanoma skin tumors.
PLEASE NOTE THE FOLLOWING IMPORTANT INFORMATION: